Table 1:
Characteristics of 40 primary breast cancers in patients who developed recurrences in the reconstructed breast.
| Histopathologic finding (40 patients) | Number of patients (%) |
|---|---|
| IDC | 33 (82.5) |
| DCIS | 3 (7.5) |
| Angiosarcoma | 1 (2.5) |
| Metaplastic carcinoma | 1 (2.5) |
| Myoepithelial carcinoma | 2 (5) |
| Cancer clinical stage (39 patients) | |
| 0 | 3 (7.7) |
| I | 14 (35.9) |
| II | 15 (38.5) |
| III | 7 (17.9) |
| Biological markers (38 patients) | |
| Luminal A | 10 (26.3) |
| Luminal B | 7 (18.4) |
| HER2+ | 5 (13.2) |
| ER−PR−HER2− | 16 (42.1) |
| Type of surgery (40 patients) | |
| Modified radical mastectomy | 26 (65) |
| Simple mastectomy | 5 (12.5) |
| Skin sparing mastectomy | 9 (22.5) |
IDC: Invasive ductal carcinoma, DCIS: Ductal carcinoma in situ, HER2: Human epidermal growth factor receptor 2, ER: Estrogen receptor, PR: Progesterone receptor